The 2020 World Congress on Controversies in Multiple Myeloma (COMy) was held virtually, on October 3–4. Experts in the field came together online to discuss and debate the latest controversies in the field.
Explore all the latest updates below!
View all videosCOMy 2020
Join us on for this upcoming IACH Journal Club
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Tuesday, March 9, 2021 7 PM (Paris, Frankfurt)
Free Registration:https://register.gotowebinar.com/register/6435702555065190160
@Mohty_EBMT
Please RT @TheEBMT @CIBMTR @TCT_ASTCT @BMTInfoNet @BMTCTN @bmtojc @iNDUSBMT @BMTjournal @NHSBT @CBTCT @BSBMTCT @NBCTransplant @SFGM_TC @i_yakoub_agha @CChabannon @AnnaSureda5 @DrMiguelPerales @bloodcancer_uk @bloodcancerclub @JCO_ASCO @TheLancetHaem @AnnalisaRugger1 @BipinSavani https://twitter.com/Mohty_EBMT/status/1368099290648875011
Please join us for the next @TheIACH journal club. Tuesday March 9, 2021 at 7PM CET. FREE registration at: https://register.gotowebinar.com/register/6435702555065190160
@nagler_EBMT @AIHemato @young_eha @JACIE_EBMT @TheEBMT_Nurses @TheEBMT_Trainee
Celebrating our UK experts for #BSW21
Hear from Gordan Cook (@LeedsHospitals) on trial designs for #Myeloma patients based on aging rather than age: http://ow.ly/nP6E50DQ1Wt
@WeHCScientists #NHS @ScienceWeekUK @BritSciAssoc #EMN21 #HemOnc #MultipleMyeloma #IAMRESILIENT2021 #MMSM
A great honor for me to lead Lymphoma portion of this trial. It is rare that a first-in-human phase 1 trial could be published in a high impact journal such as Lancet. It is another breakthrough attesting our unprecedented time, a time of accelerated science/biotech translation! https://twitter.com/viveksubbiah/status/1367849714163519490
Friday morning motivation 👉🏼Fantastic waterfall plots 👉🏼 Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study @OncoAlert https://twitter.com/viveksubbiah/status/1367681306063212553
COMy 2020
The 2020 World Congress on Controversies in Multiple Myeloma (COMy) was held virtually, on October 3–4. Experts in the field came together online to discuss and debate the latest controversies in the field.
Explore all the latest updates below!
View all videosJoin us on for this upcoming IACH Journal Club
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Tuesday, March 9, 2021 7 PM (Paris, Frankfurt)
Free Registration:https://register.gotowebinar.com/register/6435702555065190160
@Mohty_EBMT
Please RT @TheEBMT @CIBMTR @TCT_ASTCT @BMTInfoNet @BMTCTN @bmtojc @iNDUSBMT @BMTjournal @NHSBT @CBTCT @BSBMTCT @NBCTransplant @SFGM_TC @i_yakoub_agha @CChabannon @AnnaSureda5 @DrMiguelPerales @bloodcancer_uk @bloodcancerclub @JCO_ASCO @TheLancetHaem @AnnalisaRugger1 @BipinSavani https://twitter.com/Mohty_EBMT/status/1368099290648875011
Please join us for the next @TheIACH journal club. Tuesday March 9, 2021 at 7PM CET. FREE registration at: https://register.gotowebinar.com/register/6435702555065190160
@nagler_EBMT @AIHemato @young_eha @JACIE_EBMT @TheEBMT_Nurses @TheEBMT_Trainee
Celebrating our UK experts for #BSW21
Hear from Gordan Cook (@LeedsHospitals) on trial designs for #Myeloma patients based on aging rather than age: http://ow.ly/nP6E50DQ1Wt
@WeHCScientists #NHS @ScienceWeekUK @BritSciAssoc #EMN21 #HemOnc #MultipleMyeloma #IAMRESILIENT2021 #MMSM
A great honor for me to lead Lymphoma portion of this trial. It is rare that a first-in-human phase 1 trial could be published in a high impact journal such as Lancet. It is another breakthrough attesting our unprecedented time, a time of accelerated science/biotech translation! https://twitter.com/viveksubbiah/status/1367849714163519490
Friday morning motivation 👉🏼Fantastic waterfall plots 👉🏼 Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study @OncoAlert https://twitter.com/viveksubbiah/status/1367681306063212553
